Seelos Therapeutics, Inc. Business Acquisition, Pro Forma Earnings Per Share, Basic
Seelos Therapeutics, Inc. reported Business Acquisition, Pro Forma Earnings Per Share, Basic of -$0.09 per share for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic · last filed 2012-11-08
- Seelos Therapeutics, Inc. business acquisition, pro forma earnings per share, basic for the quarter ending 2012-09-30 was -$0.09.
- Seelos Therapeutics, Inc. business acquisition, pro forma earnings per share, basic for the quarter ending 2011-09-30 was -$0.11.
| Period end | Business Acquisition, Pro Forma Earnings Per Share, Basic 3 month | Business Acquisition, Pro Forma Earnings Per Share, Basic 9 month |
|---|---|---|
| 2012-09-30 | -$0.09 10-Q · filed 2012-11-08 | -$0.46 10-Q · filed 2012-11-08 |
| 2011-09-30 | -$0.11 10-Q · filed 2012-11-08 | -$0.68 10-Q · filed 2012-11-08 |